This product is sold to qualified researchers and institutions for laboratory research purposes only
By inhibiting NNMT and preserving NAD, 5-Amino-1MQ indirectly boosts SIRT1 activity , leading to: Increased fat oxidation SIRT1 activates PGC-1 (peroxisome proliferator-activated receptor gamma coactivator 1-alpha), a master regulator of mitochondrial biogenesis and fat metabolism
Yes, you should treat BPC-157 and TB-500 as prohibited for tested competition, which is why this therapy is not for competing athletes
BPC-157s angiogenesis promotion becomes especially valuable for TFCC injuries where new blood vessel formation may be the limiting factor in recovery
Food and Drug Administration and are not intended for human or veterinary use, human consumption, injection, diagnosis, treatment, cure, or prevention of any disease